The Team Behind the Architecture
Born from the intersection of advanced biophysical chemistry, synthetic biology, immunoengineering and translational medicine, we are building the next-generation framework for innovative biologics.
The Origin
The NBMods platform was born out of frustration with the status quo, paired with the synergistic capabilities that allowed us to envision what could be. As investigators across the basic, applied, and translational ecosystem, we repeatedly encountered the same hard limit: the rigid product-process coupling of traditional biologic manufacturing. We realized the industry didn't just need another vaccine candidate—it needed a fundamentally new, programmable architecture. Eureka NBE was founded to build that framework.
Core Leadership
Damian Alvarez Paggi
Founder / CEO
Daniel H. Murgida
Founder / CSO
Sebastián Esperante
Scientific Manager: Protein Engineering
Virginia Tribulatti
Scientific Manager: Immunology
Advisors
Adnan Custovic
Fernando Polack
Analía Acebal
Hugo Menzella
Salvador Ventura
Founder / CTO
Ariel Notcovich
Business Development
Medical Advisor
Medical Advisor
CMC Advisor
Technical Advisor
Damián leads the commercial and strategic execution of the NBMods framework. Leveraging his foundational expertise in immunoengineering, he bridges the critical gap between advanced synthetic biology and market viability.
Daniel directs the fundamental scientific strategy and biophysical validation of the platform. Bringing deep expertise in physical chemistry, he ensures the foundation required to translate our nanoscale designs into reproducible biological mechanisms.
Salvador drives the advanced structural engineering of the platform's architecture. As a globally recognized authority in protein folding and design, he oversees the biophysical mechanics that give the NBMods platform its combinatorial stability.
Translational Execution
Our core architecture is advanced by a dedicated translational leadership team, ensuring that every phase of development—from structural design to commercial outreach—is successfully executed